These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37720342)

  • 1. Low Rate of Bacterial Coinfections and Antibiotic Overprescribing During COVID-19 Pandemic: A Retrospective Study from Oman.
    Pandak N; Khamis F; Al Balushi Z; Chhetri S; Al Lawati A; AbouElhamd H; Golchinheydari S; Sidrah AK; Al Jahwari SK; Al Dowaiki S
    Oman Med J; 2023 Jul; 38(4):e525. PubMed ID: 37720342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial coinfections in COVID: Prevalence, antibiotic sensitivity patterns and clinical outcomes from a tertiary institute of Northern India.
    Sahu C; Singh S; Pathak A; Singh S; Patel SS; Ghoshal U; Garg A
    J Family Med Prim Care; 2022 Aug; 11(8):4473-4478. PubMed ID: 36353034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
    Chen Z; Zhan Q; Huang L; Wang C
    Front Public Health; 2023; 11():1195048. PubMed ID: 37711242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors.
    Milas S; Poncelet A; Buttafuoco F; Pardo A; Lali SE; Cherifi S
    Acta Clin Belg; 2022 Jun; 77(3):579-587. PubMed ID: 33896399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superadded Coinfections and Antibiotic Resistance in the Context of COVID-19: Where do We Stand?
    Kayarat B; Khanna P; Sarkar S
    Indian J Crit Care Med; 2021 Jun; 25(6):699-703. PubMed ID: 34316152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Bacterial Coinfection and Antibiotic Resistance in Patients with COVID-19 Under Mechanical Ventilation.
    Jamnani AN; Montazeri M; Mirzakhani M; Moosazadeh M; Haghighi M
    SN Compr Clin Med; 2022; 4(1):19. PubMed ID: 35013721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
    Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
    Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
    Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
    Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
    Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
    BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program.
    Al Rahmany D; Albeloushi A; Alreesi I; Alzaabi A; Alreesi M; Pontiggia L; Ghazi IM
    Int J Infect Dis; 2019 Jun; 83():77-82. PubMed ID: 30959249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study.
    Van Laethem J; Wuyts S; Van Laere S; Dirkx S; Seyler L; Mertens R; Ilsen B; Lacor P; Pierard D; Allard SD
    Infect Dis Ther; 2021 Dec; 10(4):2575-2591. PubMed ID: 34529255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital.
    Ceccarelli M; Marino A; Pulvirenti S; Coco V; Busà B; Nunnari G; Cacopardo BS
    Infect Dis Rep; 2022 May; 14(3):372-382. PubMed ID: 35645220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Coinfection and Antibiotic Resistance Profiles among Hospitalised COVID-19 Patients.
    Bazaid AS; Barnawi H; Qanash H; Alsaif G; Aldarhami A; Gattan H; Alharbi B; Alrashidi A; Al-Soud WA; Moussa S; Alfouzan F
    Microorganisms; 2022 Feb; 10(3):. PubMed ID: 35336071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
    Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
    PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 (COVID-19): Secondary bacterial infections and the impact on antimicrobial resistance during the COVID-19 pandemic.
    Markovskaya Y; Gavioli EM; Cusumano JA; Glatt AE
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e114. PubMed ID: 36483429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario.
    Bassetti M; Brucci G; Vena A; Giacobbe DR
    Expert Opin Pharmacother; 2023; 24(15):1679-1684. PubMed ID: 37466425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.